KE3481A - Hydrocortisone derivative - Google Patents
Hydrocortisone derivativeInfo
- Publication number
- KE3481A KE3481A KE3481A KE348184A KE3481A KE 3481 A KE3481 A KE 3481A KE 3481 A KE3481 A KE 3481A KE 348184 A KE348184 A KE 348184A KE 3481 A KE3481 A KE 3481A
- Authority
- KE
- Kenya
- Prior art keywords
- hydrocortisone derivative
- hydrocortisone
- derivative
- Prior art date
Links
- 150000001885 cortisol derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53036251A JPS6040439B2 (ja) | 1978-03-29 | 1978-03-29 | ヒドロコルチゾン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
KE3481A true KE3481A (en) | 1985-01-04 |
Family
ID=12464544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KE3481A KE3481A (en) | 1978-03-29 | 1984-12-07 | Hydrocortisone derivative |
Country Status (11)
Country | Link |
---|---|
US (1) | US4290962A (de) |
JP (1) | JPS6040439B2 (de) |
AR (1) | AR221717A1 (de) |
CH (1) | CH638227A5 (de) |
DE (1) | DE2910899C2 (de) |
FR (1) | FR2421180A1 (de) |
GB (1) | GB2020291B (de) |
IT (1) | IT1116531B (de) |
KE (1) | KE3481A (de) |
MY (1) | MY8500791A (de) |
SG (1) | SG55584G (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2826257C3 (de) * | 1978-06-15 | 1980-12-04 | Beiersdorf Ag, 2000 Hamburg | Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt |
EP0054786B1 (de) * | 1980-12-23 | 1985-03-20 | Schering Aktiengesellschaft | Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung |
DE3133081A1 (de) * | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung |
AT389447B (de) * | 1983-01-27 | 1989-12-11 | Taisho Pharmaceutical Co Ltd | Verfahren zur herstellung einer topischen steroidsalbe |
JPS59137408A (ja) * | 1983-01-27 | 1984-08-07 | Taisho Pharmaceut Co Ltd | 軟膏 |
JPS59139315A (ja) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | クリ−ム剤 |
US20060223177A1 (en) | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
JP4950659B2 (ja) | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 胎盤組織から由来最多分娩後細胞、及びそれらを作成し使用する方法。 |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
EP1663999A2 (de) * | 2003-08-29 | 2006-06-07 | Ranbaxy Laboratories, Ltd. | Inhibitoren der phosphodiesterase iv |
WO2005051931A2 (en) * | 2003-11-26 | 2005-06-09 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
US7915286B2 (en) | 2005-09-16 | 2011-03-29 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
CA2626612A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
AU2006305620A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
AU2006325710B2 (en) | 2005-12-16 | 2012-05-17 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
CN101616901A (zh) * | 2006-09-22 | 2009-12-30 | 兰贝克赛实验室有限公司 | Iv型磷酸二酯酶的抑制剂 |
EP2066661A2 (de) * | 2006-09-22 | 2009-06-10 | Ranbaxy Laboratories Limited | Phosphodiesteraseinhibitoren |
CN101611139B (zh) | 2006-11-13 | 2012-07-04 | 伊西康公司 | 利用微载体的产后来源的细胞的体外扩增 |
US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
CN103497185A (zh) | 2007-03-14 | 2014-01-08 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 |
US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
EP2111861A1 (de) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Zusammensetzungen von Phosphodiesterase-IV-Hemmern |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
CN107028983A (zh) * | 2008-12-19 | 2017-08-11 | 德普伊新特斯产品有限责任公司 | 肺部疾病和病症的治疗 |
CN104356188A (zh) * | 2014-10-23 | 2015-02-18 | 华中药业股份有限公司 | 一种丁酸氢化可的松的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1195748B (de) * | 1961-06-24 | 1965-07-01 | Vismara Francesco Spa | Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden |
GB1043347A (en) * | 1963-05-10 | 1966-09-21 | Glaxo Lab Ltd | 17,21-orthoesters of steroids |
GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
US3422193A (en) * | 1966-08-11 | 1969-01-14 | Schering Corp | 17-mono esters of corticoids |
DE2144405A1 (de) * | 1971-09-04 | 1973-03-08 | Merck Patent Gmbh | Verfahren zur herstellung von estern der pregnanreihe |
DE2826257C3 (de) * | 1978-06-15 | 1980-12-04 | Beiersdorf Ag, 2000 Hamburg | Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt |
-
1978
- 1978-03-29 JP JP53036251A patent/JPS6040439B2/ja not_active Expired
-
1979
- 1979-03-08 GB GB7908189A patent/GB2020291B/en not_active Expired
- 1979-03-14 AR AR275802A patent/AR221717A1/es active
- 1979-03-20 DE DE2910899A patent/DE2910899C2/de not_active Expired
- 1979-03-26 US US06/024,111 patent/US4290962A/en not_active Expired - Lifetime
- 1979-03-27 IT IT48501/79A patent/IT1116531B/it active
- 1979-03-28 FR FR7907832A patent/FR2421180A1/fr active Granted
- 1979-03-28 CH CH286179A patent/CH638227A5/fr not_active IP Right Cessation
-
1984
- 1984-08-07 SG SG555/84A patent/SG55584G/en unknown
- 1984-12-07 KE KE3481A patent/KE3481A/xx unknown
-
1985
- 1985-12-30 MY MY791/85A patent/MY8500791A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS54128560A (en) | 1979-10-05 |
AR221717A1 (es) | 1981-03-13 |
IT1116531B (it) | 1986-02-10 |
MY8500791A (en) | 1985-12-31 |
GB2020291A (en) | 1979-11-14 |
FR2421180A1 (fr) | 1979-10-26 |
DE2910899A1 (de) | 1979-10-11 |
CH638227A5 (fr) | 1983-09-15 |
DE2910899C2 (de) | 1986-02-13 |
SG55584G (en) | 1985-03-08 |
IT7948501A0 (it) | 1979-03-27 |
US4290962A (en) | 1981-09-22 |
GB2020291B (en) | 1982-10-06 |
FR2421180B1 (de) | 1982-10-22 |
JPS6040439B2 (ja) | 1985-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY8500791A (en) | Hydrocortisone derivative | |
JPS54109975A (en) | Thienohydantoin derivative | |
JPS54141798A (en) | 44desacetyl vlboo33carboxyhydrazide derivative | |
JPS54119450A (en) | 2hhbenzofurann33one derivative | |
JPS5527193A (en) | Spiroofuranohydantoin derivative | |
JPS54132627A (en) | Cumalin derivative | |
GB2022079B (en) | L-leucyl-4-hydroxyanilide derivatives | |
JPS54151966A (en) | Nnsubstituted oxobenzothiazoline derivative | |
GB2018757B (en) | 3-phenyltetrahydropyridine derivatives | |
PH17055A (en) | Delta4-androstenes derivative | |
GB2017708B (en) | Steroid-spirooxazolidinone derivatives | |
JPS54128573A (en) | Cholestane derivative | |
JPS54128570A (en) | Arylaminoimidazoline derivative | |
GB2019843B (en) | N-alkenylmoranoline derivatives | |
GB2017691B (en) | 2-hydroxymethyl-pyrazine derivatives | |
JPS5543080A (en) | 22oxazolin derivative | |
GB2024806B (en) | Onomycin derivatives | |
JPS54163596A (en) | Flonaphlizine derivative | |
JPS54109991A (en) | 111alkanoyll4***deoxyy4***isonitroooleandomycin derivative | |
GB2013187B (en) | Phenylpyrol derivatives | |
GB2023574B (en) | N-cyano-azomethine derivatives | |
JPS557262A (en) | Novel bettaine derivative | |
JPS5581835A (en) | Novel pentenee22yl derivative | |
JPS54151967A (en) | Nnsubstituted oxobenzothiazoline derivative | |
JPS54122232A (en) | Phenylnitramine derivative |